Related Experiment Video
Updated: Jun 15, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Impact of benign prostatic hyperplasia surgery on erectile function
José M Martínez-Jabaloyas1, Rafael Villamón-Fort, Manuel Gil-Salom
1Servicio de Urología, Hospital Clínico Universitario de Valencia, Valencia, Spain. jaba @ pulso.com
Erectile dysfunction (ED) is common in men undergoing benign prostatic hyperplasia (BPH) surgery. While post-surgical ED can worsen, many patients experience improved erectile function (EF).
Area of Science:
- Urology
- Andrology
- Men's Health
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Erectile dysfunction (ED) frequently coexists with BPH.
- Surgical intervention for BPH may impact pre-existing or potential ED.
Purpose of the Study:
- To determine the prevalence of ED before BPH surgery.
- To assess changes in erectile function (EF) after surgical treatment for BPH.
- To identify clinical variables influencing EF outcomes post-BPH surgery.
Main Methods:
- Prospective study of 128 male patients undergoing surgical BPH treatment.
- Assessment of ED using the International Index of Erectile Function (IIEF) pre- and post-surgery.
- Uni- and multivariate analyses to correlate clinical variables with EF changes.
Main Results:
- Pre-operative ED prevalence was high, with 68% of patients experiencing some degree of ED.
- Mean IIEF scores showed no significant change post-surgery (20.5 pre-op vs. 21.5 post-op).
- Post-surgery, 26.6% of patients reported improved EF, while 18.8% experienced worsening (p < 0.05).
Conclusions:
- A significant proportion of men seeking BPH surgery have pre-existing ED.
- While post-surgical worsening of EF is a risk, a notable percentage of patients with ED experience improvement.
- No specific clinical variables consistently predicted EF improvement or worsening, except age in non-ED patients.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
